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Visual Abstract
Significance Statement
We describe a novel neural manipulationmethod using laser and liposomal nanostructures. Themethod enables
us to release various types of neurochemicals and drugs in the mouse brain, beyond the range used by existing
optical manipulation methods, such as optogenetics and caged compounds. We also demonstrate repeated
and stable neural manipulation modulated by laser intensity. Given the established biocompatibility and stability
of liposomes in the body, these findings suggest that the liposomal neural manipulation methods would be a
useful tool for neuroscience research and further treatment of neurological disorders.
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External control over rapid and precise release of chemicals in the brain potentially provides a powerful interface
with neural activity. Optical manipulation techniques, such as optogenetics and caged compounds, enable
remote control of neural activity and behavior with fine spatiotemporal resolution. However, these methods are
limited to chemicals that are naturally present in the brain or chemically suitable for caging. Here, we demonstrate
the ability to interface with neural functioning via a wide range of neurochemicals released by stimulating loaded
liposomal nanostructures with femtosecond lasers. Using a commercial two-photon microscope, we released
inhibitory or excitatory neurochemicals to evoke subthreshold and suprathreshold changes in membrane potential
in a live mouse brain slice. The responses were repeatable and could be controlled by adjusting laser stimulation
characteristics. We also demonstrate the release of a wider range of chemicals—which previously were impos-
sible to release by optogenetics or uncaging—including synthetic analogs of naturally occurring neurochemicals.
In particular, we demonstrate the release of a synthetic receptor-specific agonist that exerts physiological effects
on long-term synaptic plasticity. Further, we show that the loaded liposomal nanostructures remain functional for
weeks in a live mouse. In conclusion, we demonstrate new techniques capable of interfacing with live neurons,
and extendable to in vivo applications.
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Introduction
The development of optical methods for manipulating
neurons has revolutionized the investigation of causal
relationships between neural activity and function, with
the potential to add to the understanding of mechanisms
and the treatment of neurological disorders. A particular
strength of optical methods is the ability to interact with
neurons with fine spatiotemporal resolution (Callaway and
Yuste, 2002; Szobota and Isacoff, 2010; Shepherd, 2012;
Lim et al., 2013), but existing methods have some impor-
tant limitations. Until now, caged compounds and opto-
genetic methods have been the principal methods of
optical manipulation. Caged compounds are made by
bonding caging moieties with target chemicals, such as
calcium, glutamate (Glu), and dopamine (Ellis-Davies,
2007). When optically stimulated, the caged compounds
undergo photolysis and release the target chemicals. Un-
caging techniques, however, are limited in the range of
compounds that can be caged and may require complex
synthesis procedures. In addition, they are limited to
“one-shot” nonrepeatable release from each caged mol-
ecule. The more recent optogenetic method allows optical
manipulation of neurons that are genetically modified to
express light-activated protein (Papagiakoumou et al.,
2010; Yizhar et al., 2011). Optogenetic stimulation can
both activate and inhibit neurons, and, thus, can control
neurotransmitter release from neurons. However, optoge-
netic stimulation is limited to releasing neurotransmitters
that are naturally synthesized by genetically targeted neu-
rons. Due to these limitations, no existing method can
stimulate the release of arbitrarily selected neurochemi-
cals and drugs with amplitude controlled locally, repeat-
edly, and rapidly. We here report a new optical method
enabling the use of a more complete pharmacopoeia of
neurochemicals and drugs to specifically stimulate or in-
hibit particular receptors or ion channels, with high spa-
tiotemporal resolution and repeatability.
In previous work, a new method of chemical release
from liposomal nanostructures using optical stimulation
was described (Wu et al., 2008; Leung and Romanowski,
2012; Nakano et al., 2014; Huang et al., 2015). Liposomal
nanostructures are submicron spherical capsules com-
prising a lipid bilayer shell and an interior space that can
be loaded with drugs. By tethering a gold nanoparticle to
the liposome wall, the repeatable release of the encapsu-
lated drug from the liposome can be effected by exposure
to femtosecond laser pulses (Nakano et al., 2014). By
adjusting laser stimulation parameters, the amount and
speed of release can be controlled. In addition to the
biocompatibility and capability to encapsulate many
types of chemicals, this method has the favorable char-
acteristic of providing rapid, on-demand, and repeatable
delivery on a physiological timescale. Although these “in-
beaker” results indicate the potential of this method for
the manipulation of neural activity in neuroscience re-
search, until now it has not been applied in living brain
tissue.
In this study, we demonstrate experimental manipula-
tion of neural activity in live mouse brain tissue by laser-
stimulated release of neurochemicals from liposomal
nanostructures, releasing a range of different neuro-
chemicals, drugs, and metal ions. We also show that the
amount of release from liposomes can be controlled, and
that the release is repeatable and reliable. Importantly, we
demonstrate the release of a wider range of chemicals
than is possible using optogenetics or uncaging. In par-
ticular, we show that the release of a pharmacological
agent, a synthetic receptor-specific agonist, could exert
physiological effects on long-term synaptic plasticity.
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These experiments demonstrate new possibilities for neu-
ral manipulation based on liposomal nanostructures.
Materials and Methods
Slice preparation
Animals were handled in accordance with protocols
approved by the animal care and use committee of
authors’ university. Experiments were performed on
male Drd1a-eGFP BAC transgenic mice bred on a
Swiss Webster background (inbred; The Jackson Labo-
ratory) and a C57BL/6 cross [age, postnatal day 30 (P30)
to P80]. Animals were deeply anesthetized with isoflurane
and decapitated, and the brain was removed rapidly.
Horizontal slices, 300 mm thick, containing the hippocam-
pus and entorhinal cortex or oblique horizontal corticos-
triatal slices were cut on a vibratome (VT1200S, Leica
Microsystems) in a cold cutting solution containing the
following (in mM): 92.0 N-methyl-D-glucamine, 2.5 KCl,
10.0 MgCl2, 0.5 CaCl2, 1.25 NaH2PO4, 30.0 NaHCO3,
20.0 HEPES, 2.0 thiourea, 5.0 sodium ascorbate, 3.0
sodium pyruvate, and 25.0 glucose, and saturated with
95% O2/5% CO2 (VT1200S, Leica). Slices were then in-
cubated in oxygenated artificial CSF (ACSF) maintained at
a temperature of 36°C for 1 h. The standard ACSF had the
following composition (mM): 118.0 NaCl, 2.5 KCl, 2.0
CaCl2, 1.0 MgCl2, 26.0 NaHCO3, 1.25 NaH2PO4, 1.5
myo-inositol, 0.5 sodium ascorbate, 2.0 sodium pyruvate,
and 10.0 glucose. After incubation, a single slice was
transferred to a recording chamber placed on the stage of
an upright microscope, and perfused (3–4 ml/min) with
oxygenated ACSF at 32°C. The remaining slices were
kept in a holding chamber containing oxygenated ACSF
at room temperature until required.
Electrophysiological recording
Whole-cell recordings were made from CA1 pyramidal
neurons in hippocampus or the D1-type dopamine recep-
tors expressing medium spiny neurons in the striatum.
Patch pipettes (4–6 M) were filled with internal solution
containing the following (in mM): 132.0 K gluconate, 6.0
KCL, 6 NaCl2, 10.0 HEPES, 2 MgCL2, 2.0 NaATP, 0.4
NaGTP, and 0.5 EGTA, pH 7.2–7.4. Signals were ampli-
fied by MultiClamp 700B (Molecular Devices), digitized at
10,000 Hz and filtered with a band of 1–2,000 Hz by
pCLAMP 10 (Molecular Devices). Off-line analysis was
conducted using MATLAB (MathWorks).
Preparation of liposomal nanostructures
Drugs and chemicals that were encapsulated in lipo-
somes were all dissolved in Dulbecco’s PBS (catalog
#14040133, ThermoFisher Scientific) as follows: Glu, 100
mM L-glutamic acid (Tocris Bioscience); carboxy-fluorescein
(CF), 1 mM 6-carboxy-fluorescein (Bachem Feinchemikalien
AG); potassium chloride (KCl), 2.6 M KCl plus 1 mM CF;
muscimol, 100 mM muscimol (Tocris Bioscience) plus 1 mM
CF; D1 Agonist (SKF), 12 mM SKF-38393 hydrochloride
(Tocris Bioscience) plus 36 mM L-ascorbic acid sodium salt
(Nacalai Tesque); and ascorbic acid, 36 mM L-ascorbic acid
sodium salt (Nacalai Tesque).
Liposomal nanostructures were assembled from lipo-
somes, tethering molecules, and hollow gold nanoshells
(HGNs). To prepare the liposomes, the following com-
pounds were combined in a flask in the molar ratios of
100:5:5:4:3.5, 1,2-distearoyl-sn-glycero-3-phosphocholine
(Echelon Biosciences), cholesterol (Nacalai Tesque), sphin-
gomyelin (Avanti Polar Lipids), 1,2-distearoyl-sn-glycero-3-
phosphoethanolamine-N-[methoxy(polyethylene glycol)-
2000] (DSPE-PEG2000, Avanti Polar Lipids), and the
tethering molecule DSPE-PEG2000-SH dissolved in chloro-
form (Nacalai Tesque). A thin film of this lipid mixture was
then deposited on the surface of the flask by heating and
evaporating the lipid mixture under reduced pressure while
warming the flask in warm water. The thin lipid film was
suspended in a buffer solution (0.8 ml PBS) containing the
drug to be encapsulated by swirling in a water bath at 50°C
until all the lipid material was suspended. Immediately after-
ward, uniformly sized liposomes were obtained by extrusion
of the suspension through a 400 nm polycarbonate mem-
brane at a temperature above the transition temperature of
the lipids. Based on a study of filter-extruded liposomes by
Hinna et al. (2016), we expect that most of the liposomes are
unilamellar with a minority of bilamellar (multiwalled) ones in
the mix. The suspension of tether-ready liposomes was then
placed in a sample vial (15–20 ml capacity).
To link the gold nanoshells, the HGNs were first sus-
pended in HEPES buffer, 10 mM, pH 7.3, gold 8.1 mg/ml.
The diameter of the HGNs was20 nm with absorption in
the visible and near-infrared regions. The HGN suspen-
sion was added to the liposome suspension in aliquots of
2.9 l while the solution was agitated on a vortex mixer.
After each addition of HGN, the suspension was left
unstirred for 5 min. A total of 20 aliquots were added in
this manner. Using this method, we estimate that on
average one HGN is attached to each liposome. The
encapsulation efficiency (5.3%) was calculated from the
percentage volume within the liposomes compared with
the total volume of drug solution used for suspending the
lipids. To estimate release, we referred to previous work
(Nakano et al., 2014) in which release from liposomes
trapped on a carbon fiber was determined by measuring
the oxidation current of dopamine. By fitting an exponen-
tial curve to a series of release events, the fraction of the
cargo released at each event was estimated as 5.8%. The
liposome suspension was then placed inside dialysis tub-
ing and dialyzed with PBS buffer, which was stirred during
dialysis.
Laser stimulation
We used a two-photon microscope (FV1000, Olympus)
to stimulate the liposomal nanostructures. The two-
photon microscope has an infrared (890 nm) femtosecond
laser, with pulse widths of 100 fs and a repetition rate of
80 MHz. Laser pulses were transmitted through a 60 or
40 objective lens and focused to a 430 nm spot size in
the brain slice, which was then scanned over an area with
dimensions of 212  212 m (60) or 318  318 m
(40). Laser power at the source of 2 W is intensified at
the sample (800 kW/cm2) and attenuated by an acousto-
optic modulator. A single spot (pixel) had a dwell time of
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2 s (160 pulses). The laser stimulation setting was soft-
ware controlled (FluoView, Olympus).
Plasticity experiments
EPSPs were evoked in D1 receptors expressing me-
dium spiny neurons in the striatum by extracellular stim-
ulation with bipolar electrodes placed in the corpus
callosum. Stimulation intensity (0.1–3.0 mA, 0.2 ms dura-
tion) was adjusted to evoke baseline EPSPs with ampli-
tudes of 1–6 mV. Baseline EPSPs were recorded for 10
min at a 0.05 Hz stimulation rate.
After the baseline period, a plasticity-inducing stimula-
tion was applied that consisted of 0.2 s suprathreshold
postsynaptic current injections paired with 20 Hz electri-
cal stimulation of the cortex to produce a presynaptic and
postsynaptic conjunction of activity, which would nor-
mally produce long-term depression. Liposomal nano-
structures were irradiated with a laser that commenced
output from 0.4 s after the onset of the current injection
and continued for 0.43 s. This conditioning stimulation
protocol was repeated four times at 30 s intervals. The
change in EPSP amplitude was evaluated by averaging
the responses that were evoked in the period 10–20 min
after the conditioning. For group averages, responses
were expressed as the percentage change from the base-
line EPSP amplitude. Data are presented as the mean 
SEM.
Statistical analysis
Statistical analysis was undertaken to test the effective-
ness of the liposomes, comparing baseline and evoked
responses using Student’s t test, accepting a significance
level of p  0.0001. To determine the significance of the
regression analysis, we tested the null hypothesis that the
coefficient is equal to zero (no effect), using a significance
level set to p  0.001. For the plasticity experiments
involving comparison across groups, analysis of variance
(repeated measures design) using the general linear
model procedures (SPSS, IBM) was used with  set to p
 0.05.
Results
In order to test their effectiveness in live brain tissue,
liposomal nanostructures were loaded with different
agents and injected into area CA1 of the hippocampus.
The volume injected was estimated to be 3–5 nl based on
the diameter of the volume observed in bright-field im-
ages displayed on a monitor screen. Based on the lipo-
Figure 1. Experimental setup. A, Diagram showing relative positions of recording electrode in hippocampus and laser illumination.
Whole-cell recordings were made from pyramidal neurons using patch electrode positions in the liposome-injected region. B,
Enlargement of the area shown by the oblique rectangle in A. Laser stimulation was applied to the pyramidal neuron dendritic region
by scanning, so that the laser lit small regions one by one, with a laser dwell time of 2 s. The small rectangle shows the laser scan
crossing the dendrite in the region of liposome injection. C, Enlargement of the small rectangle shown in B, showing the location of
liposomes in relation to dendrites and dendritic spines. Laser-stimulated liposomes release drugs close to dendritic spines. D,
Liposomes were assembled from components, as described previously. Adapted from the study by Nakano et al. (2014) with
permission of the authors. Laser spot, Neuronal structures and liposomes not drawn to scale.
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somal formulation, we estimated 3.2 million liposomes per
nanoliter. To measure release, we made whole-cell re-
cordings from hippocampal CA1 pyramidal cells during
exposure of the injected area to laser stimulation (Fig. 1A).
The recorded cells were 500 m distant from the center
of the bolus injection, within the pore space of the injected
material. As the laser scanned the area, the focal point of
illumination passed over the injected liposomal nanostruc-
tures in the stratum radiatum (Fig. 1B). Laser-stimulated
release of substances caused membrane potential re-
sponses, which differed according to the types of receptors
or ion channels involved, and their relative location on den-
dritic spines and dendrites (Fig. 1C).
When liposomes were loaded with the excitatory
neurotransmitter glutamate, laser stimulation evoked a
transient depolarization of the cell membrane, with a sub-
second timecourse (Fig. 2A1 ). Depolarizations (mean,
4.98  0.41 mV; p  0.0001 vs baseline; n  6) could be
evoked reliably and repeatably (50 repetitions). Depo-
larizations occurred with constant latency from the onset
of each scan period, consistent with release from one or
more liposomes excited at a certain point in the scan. The
same intensity of stimulation was able to evoke action
potential firing of CA1 pyramidal cells when the injection
volume was increased several fold (Fig. 2A2), presumably
due to the release of greater quantities of glutamate.
To test the ability of the system to release a wider range of
substances than previously possible, we tested liposomes
loaded with the GABAA receptor agonist muscimol, a syn-
thetic compound not available for pulsatile application by
electrical, optogenetic, or uncaging methods. Stimulation of
muscimol-containing liposomes caused a transient hyper-
polarization (mean, 	1.87  0.20 mV; p  0.0001 vs base-
line; n  5) of the membrane potential (Fig. 2B) consistent
with its known pharmacological actionsmediated by binding
to GABAA receptors. This demonstrates the possibility of
phasic release of a synthetic agent on a subsecond time-
scale.
To test their effectiveness in delivery of small ions,
liposomes were loaded with potassium chloride. Lipid
bilayer membranes are relatively impermeable to potas-
sium chloride, which dissociates into K
 and Cl	 in water,
both of which are charged and have relatively large hy-
dration spheres. Published permeability coefficients for
the passage of K
 and Cl	 through synthetic lipid bilayers
are 10	10 cm/s (Alberts et al., 2002, their Fig. 11-2).
Therefore, we tested whether laser stimulation of potas-
sium chloride-containing liposome would cause release,
detectable as changes in the membrane potential of the
recorded cells. We found that laser stimulation caused
neural depolarization (mean, 5.96  0.28; p  0.0001 vs
baseline; n  5) consistent with a change in the local
extracellular concentration of potassium and a conse-
quent shift in the equilibrium potential of the leak conduc-
tances of the cells (Fig. 2C). These responses were also
repeatable 50 times. Together with the foregoing re-
sults, these findings suggest that the method has the
potential to provide novel types of control over neural
activity by pulsatile application of a broader range of
neurochemicals, drugs, and ionic compounds than has
previously been possible.
We then investigated the reliability of control of neural
function by liposomal release using glutamate-containing
liposomes (Fig. 3). We first measured the neural re-
Figure 2. Whole-cell recordings of neural responses to laser stimulation of liposomal nanostructures. A1, Subthreshold membrane
potential depolarization in response to laser stimulation (320 kW/cm2) of glutamate-loaded liposomes. A2, Action potential responses
in response to stimulation at same intensity (320 kW/cm2), using a higher concentration of liposomes. B, Hyperpolarizing responses
to stimulation (800 kW/cm2) of liposomes loaded with the GABA agonist muscimol. C, Depolarizing response to stimulation (8
kW/cm2) of KCl-containing liposomes. Each trace (A1, A2, B, and C) shows the mean of four to six responses, with individual
responses overlaid. Note that spot scanning may stimulate release at time points that are delayed relative to scan onset. Bar indicates
the duration of a single scan.
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sponses to the laser stimulation of glutamate-loaded lipo-
somes as we varied the laser power, using a liposome
concentration that produced subthreshold membrane po-
tentials. We found that the amplitude of the responses
changed systematically as we varied the laser power, with
stronger laser stimulation causing a larger response am-
plitude (Fig. 3A), and, on average, were approximately
linearly related (r2  0.98, p  0.001, n  30) to the
intensity up to 640 kW/cm2 (Fig. 3B). The subthreshold
responses were repeatable over many trials (30) with
stable amplitude (Fig. 3C), confirmed statistically by the
lack of significant difference of the regression coefficient
from zero at 160 kW/cm2 (p  0.07, nonsignificant), 480
kW/cm2 (p  0.47, nonsignificant), or 800 kW/cm2 (p 
0.41, nonsignificant).
At higher power settings, even though the exposure
period is brief, it is possible that the intensity of stimula-
tion may have direct effects on the membrane potential. In
order to confirm that the responses were caused by the
glutamate release from laser-stimulated liposome, and
not by the direct effects of the laser on the neural pro-
cesses or liposomes themselves, we exposed PBS-
containing liposome to the laser as a control experiment.
The laser stimulation to the PBS-containing liposome did
not cause depolarizing responses (Fig. 3D), and there was
no significant indication of an association of membrane
potential with power level (p  0.08, nonsignificant). To-
gether with the significant effects of glutamate-loaded
liposomes, these results show that liposomal drug appli-
cation can be used repeatedly to cause membrane
potential depolarizations of controlled amplitude, thus
providing a novel means of interfacing light and neural
activity that does not require genetic manipulation or
depend on the chemical properties of the agents.
To investigate whether the liposomal nanostructures
could be used to produce physiological changes by the
release of specific dopamine agonist drugs, we tested the
effectiveness of liposomal nanostructures in modulating
activity-dependent synaptic plasticity in the striatum. Pre-
viously, the neuromodulator, dopamine—acting via dopa-
mine D1 receptors—has been known to modulate
synaptic plasticity in the striatum (Reynolds et al., 2001).
However, tonic stimulation of dopamine D1 receptors by
dopamine D1-selective agonist drugs does not have this
effect. We hypothesize that the effect requires phasic
activation of the receptor, because of the rapid desensi-
tization of dopamine D1 receptors when constantly ex-
posed to agonists (Ofori et al., 1993) and previous studies
showing that pulsatile application, but not bath applica-
tion, of dopamine causes long-term potentiation (Wickens
et al., 1996).
To test this hypothesis, we used liposomes loaded with
the dopamine D1 agonist SKF-38393, and laser stimula-
tion to phasically activate the dopamine D1 receptors.
Using corticostriatal slices from transgenic mice in which
EGFP is selectively expressed in D1 receptor-expressing
medium spiny neurons of the striatum, we measured
EPSPs before and after an experimental treatment involv-
Figure 3. Repeated and amplitude-controlled release by liposome. A, Subthreshold neural responses to different laser power. The
black bar indicates the laser exposure. Each trace is the average of 30 responses. B, Response amplitude for successively increased
laser power, showing the average and SEM at each power level. There is a good fit to a regression line y  0.0095x–0.075 with R2
 0.98. C, Repeatability of subthreshold responses over 30 repetitions of the same stimulus at three different laser power settings.
D, Control experiment using PBS containing liposome shows small amplitude responses to laser exposure.
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ing activity and phasic dopamine D1 receptor stimulation.
EPSPs were evoked in the medium spiny neurons by
stimulating the corpus callosum, and test responses were
recorded before and after an experimental treatment.
Liposomes loaded with SKF-38393 plus ascorbic acid
in PBS (D1 agonist experimental group), or ascorbic acid
alone in PBS (vehicle controls) were injected into the slice
in advance of the recording. Ascorbic acid was used to
reduce oxidation of the dopamine agonist. To induce
synaptic plasticity, electrical stimulation of presynaptic
inputs was repeatedly paired with firing of the postsynap-
tic neurons, a protocol that is expected to produce long-
term depression based on previous studies (Wickens
et al., 1996; Shindou et al., 2011). Phasic release of
SKF-38393 plus ascorbic acid or ascorbic acid alone (Fig.
4A) was paired with the electrical stimulation. After pair-
ing, the amplitude of EPSPs in the DA agonist group
increased significantly relative to that of the controls, and
remained increased for the duration of the recording
(mean normalized EPSP 1–20 min after pairing: control,
0.81  0.10 mV, n  7; SKF-38393, 1.12  0.08 mV, N 
11; p  0.05, Fig. 4B,C), long outlasting the application of
SKF-38393, indicating a modulatory effect on long-term
plasticity of synaptic responses. The example cell shown
exhibited a very large potentiation, possibly indicating a
favorable location of liposomes relative to the synapses
mediating the postsynaptic response, while other cells
showed fewer dramatic changes, as indicated in the
group averages (Fig. 4D, SKF-38393). The cell shown
exhibited the largest potentiation seen, well above the
average, was treated as an outlier, and was not included
in the statistical analysis. In contrast, the amplitude of
EPSPs decreased after conditioning using liposome
loaded with only ascorbic acid (Fig. 4D, controls). These
findings support the hypothesis that phasic activation of
dopamine D1 receptors is sufficient for the induction of
dopamine D1 receptor-dependent synaptic plasticity.
A crucial question is the suitability of the liposomes for
use under in vivo conditions. To test the durability of
liposome in live animals, we made injections of glutamate-
and 6-CF-containing liposomes into the cerebral cortex
stereotaxic coordinates [anteroposterior (AP), 1.1; medio-
Figure 4. Dopamine D1 receptor-mediated synaptic plasticity. A, The top trace shows membrane potential during conditioning. Lower
traces show the conditioning stimulation protocol. Conditioning stimulation was a combination of cortical stimulation (four pulses at
20 Hz) and suprathreshold postsynaptic current injection paired with cortical stimulation. Laser stimulation (0.43 s scan, 2 s dwell
time at 400 kW/cm2) was delayed 0.4 s. B, An example of the change in the synaptic responses. The synaptic response increased
after the conditioning using SKF-38393 containing liposome, while resting membrane potentials and input resistance remain
unchanged. C, Examples of EPSPs before and after conditioning. The black line indicates preconditioning, and the red line indicates
postconditioning corresponding to the bar in B. D, Group average of the change in the synaptic efficacy using SKF containing
liposome (red) or ascorbic acid containing liposome (black). Values are reported as the mean  SEM.
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lateral (ML), 1.5; dorsoventral (DV), 1.4; Fig. 5A], and
tested functionality at 1 week and 1 month after the
injection. One week after injection, following the prepara-
tion and superfusion of brain slices during maintenance
and in the recording chamber, opacities indicating the
presence of liposomes could be seen under infrared dif-
ferential interference contrast illumination at low magnifi-
cation (Fig. 5B). Whole-cell recordings from pyramidal
neurons in these slices showed that laser stimulation at
low power (8 kW/cm2) evoked subthreshold membrane
potential depolarizations (mean, 7.12  0.30 mV; p 
0.0001; n  10; Fig. 5C). Suprathreshold responses were
evoked at higher laser power (160 kW/cm2; Fig. 5D). As
previously shown for acutely injected liposomes, the tran-
sient depolarizations could be evoked reliably and repeat-
edly over several trials (Fig. 5E). These findings show that
liposomes survive in the brain of living animals and remain
functional for at least 1 week.
One month after injection into a similar cortical region
(AP, 0.6; ML, 1.5; DV, 1.5), opacities could still be seen
(Fig. 6A). In slices made from these animals, laser stimu-
lation at low power evoked minimal release of CF (Fig.
6B). Substantial release was observed at higher laser
stimulation power (Fig. 6C), and this was associated with
subthreshold depolarization (Fig. 6D). However, with re-
peated stimulation the response amplitude decreased
over 25 release episodes, suggesting that after 1 month in
vivo the proportion of fragile liposomes has increased
(Fig. 6E).
Discussion
We have demonstrated that drug-encapsulated lipo-
somes provide an interface with neural activity when stim-
ulated by femtosecond laser pulses. This technique
allows the encapsulation of a wide variety of neurochemi-
cally active substances, including glutamate, potassium
chloride, and muscimol and specific dopamine agonists.
By varying laser power, it is possible to control the release
of neurochemicals, in turn modulating the neural re-
sponses. The evoked neural responses were repeatable
and stable. Importantly, the liposomes are compatible
Figure 5. Liposome functionality after 1 week in vivo. A, Liposomes were stereotaxically injected into cerebral cortex at the location
shown. See text for stereotaxic coordinates. B, Bright-field image of injected liposome in brain slice, after slice preparation and
maintenance in the recording chamber. A dotted line encircles the area darkened by the presence of gold nanoparticles. Scale bar,
200 m. C, Subthreshold neural response repeatedly evoked by laser stimulation (8 kW/cm2). Dark trace shows the mean of 10
responses, with individual responses overlain. D, Spikes repeatedly evoked by stimulating liposome by laser at higher power (160
kW/cm2) 1 week after stereotaxic injection into the mouse brain. E, Repeatability of responses (0.254s, 2 s dwell time, 8 kW/cm2)
over 20 episodes (includes data from C). Interstimulus interval, 30 s (C–E).
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with brain tissue and remain stable in the living brain for
long periods.
The mechanism of light-induced release from gold-
tethered liposome structures is not yet known, but there
are several possibilities and clues from previous studies.
We previously proposed that the following two different
processes are involved: a process that may involve one-
time destruction of a fragile subset of the liposomes; and
a more common nondestructive and repeatable process
in which the liposome wall becomes temporarily perme-
able to the contents and then reseals, allowing multiple
release events. Paasonen et al. (2007) proposed that
HGNs, via the linker molecules, may transfer heat to the
liposomal wall and increase its fluidity. Similarly, Wu et al.
(2008) suggest that release is caused by transient cavita-
tion due to microbubble formation and collapse within the
liposome wall. Both mechanisms involve steep tempera-
ture gradients that require femtosecond pulse irradiation.
Importantly, the present formulation is dominated by the
nondestructive process, as evidenced by SEM confirma-
tion of the persistence of liposomal nanostructures before
and after light-stimulated release (Nakano et al., 2014).
A particular advantage of this technique, compared with
other optical stimulation techniques, is the ability to encap-
sulate a variety of chemicals. This allows the controlled
release of not just intrinsic neurotransmitters, but also
artificial molecules, such as selective receptor agonists, an-
tagonists, and ion channel blockers. This enables the stim-
ulation of particular subtypes of receptors or the blockade of
specific ion channels, making a large arsenal of experimental
tools available for reliable and repeatable delivery on a sub-
second timescale. In comparison, optogenetic neural ma-
nipulation is limited to releasing naturally synthesized
neurotransmitters from genetically modified neurons. While
Figure 6. Survival of liposomes after 1 month in vivo. A, Image of injected liposome in the brain slice. Dark material indicates the
presence of gold nanoparticles. Scale bar, 200 m. B, C, Two-photon images showing the fluorescence of released CF during laser
scanning at 10% (B) and 50% (C) of maximum power. Scale bar, 50 m. D, Electrophysiological response of neurons recorded during
laser stimulation in B (black trace) and C (red trace), showing depolarization in response to higher power. E, Repeatability of response
amplitude over 20 episodes (interstimulus interval, 30 s). The decrease in response amplitude fitted a single exponential decay (fitted
curve, y  2.41e	0.1488x).
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optogenetics provides unparalleled advantages for manipu-
lating existing neural systems, it cannot substitute for neural
functions that have been lost due to neurodegeneration or
release novel, artificially synthesized pharmacological
agents. Similarly, uncaging techniques are limited to com-
pounds that have a molecular structure that is suitable for
covalent binding to caging moieties, in turn limiting the
possibilities of neural interfacing.
By varying laser intensity and pulse-timing parameters,
laser-stimulated release from liposomes can be flexibly
controlled. This flexibility is an advantage over caged
compounds, which have a threshold-like, nonlinear char-
acteristic due to the photolytic processes involved in
uncaging, and do not produce smoothly graded variation
in release amount. The graded release that is possible
from liposomes thus provides a wider and more continu-
ous range over which neuronal function can be manipu-
lated.
The combination of spatiotemporally controlled re-
lease, along with the variety of available neurochemi-
cals, also allows for other novel studies of neural
functioning, which are not possible with existing meth-
ods. Further developments in the architecture of the
gold nanoparticles tethered to the liposomes may en-
able selectivity in excitation wavelengths, such that, in
principle, one could inject two populations of lipo-
somes, both loaded with different neurochemicals, that
respond to different wavelengths of light. This allows
the possibility of multichannel stimulation. Last, we
note that liposomes are highly biocompatible, and are
not toxic to living tissue. We have demonstrated that
the liposomes survived and stayed at the injected site
for weeks while retaining the ability to release the en-
capsulated neurochemicals. These characteristics are
well suited for in vivo experiments and provide the
possibility of addressing neurological diseases in the
future.
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